Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06623435 · ClinicalTrials.gov registry record
Real World and Genomic Data Based Asthma Insight Through Network Analysis
A clinical trial of Asthma, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- 1,073
- Enrollment target
- 5
- Study locations
NCT06623435 is a study of Asthma that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,073 participants, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (31% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT06623435, a study of Asthma, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- 1,073 participants
- Enrollment target
- 5
- Study locations
Study Summary
A retrospective and prospective observational study of asthma designed to determine real-world and molecular description of asthma according to treatment and type 2 biology
Conditions Studied
Study Locations (5)
New York
- Mount Sinai Beth Israel - New York
- Mount Sinai West - New York
- Mount Sinai Morningside - New York
- Mount Sinai Hospital - New York
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,073 participants |
| Start Date | 2019-11-07 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06623435
The ClinicalTrials.gov registry entry for NCT06623435 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,073 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,560-participant average among 374 other Asthma trials with a reported enrollment target (31% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT06623435 reports 5 study locations spanning 2 distinct geographic areas - top geographies include New York, Colorado.
Frequently Asked Questions
What is clinical trial NCT06623435 about?
NCT06623435 is a clinical study titled "Real World and Genomic Data Based Asthma Insight Through Network Analysis". A retrospective and prospective observational study of asthma designed to determine real-world and molecular description of asthma according to treatment and type 2 biology
What is the current status of trial NCT06623435?
This trial is currently active not recruiting. The enrollment target is 1,073 participants. The study started on 2019-11-07. Estimated completion is 2025-12-31.
What conditions does trial NCT06623435 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT06623435?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06623435 being conducted?
This trial has 5 study locations across Colorado, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.